Postnatal Growth Trajectories and Neurodevelopmental Outcomes Following Bevacizumab Treatment for Retinopathy of Prematurity.

Clin Ophthalmol · 2022 · PMC9401100 · PMID 36035240

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to achieve significanceno p-value reported

However, after applying the false discovery rate correction for multiple testing, this finding failed to achieve significance (q > 0.99).

also in 299 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.